nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Epirubicin—bone cancer	0.482	0.653	CbGbCtD
Moxifloxacin—TOP2A—Doxorubicin—bone cancer	0.256	0.347	CbGbCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—C21orf33—bone cancer	0.0103	0.299	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.00593	0.173	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00141	0.041	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.00115	0.0336	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000994	0.029	CbGpPWpGaD
Moxifloxacin—TOP2A—Doxorubicin—Epirubicin—bone cancer	0.000969	0.173	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Epirubicin—bone cancer	0.000969	0.173	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Epirubicin—bone cancer	0.000969	0.173	CbGdCrCtD
Moxifloxacin—TOP2A—Epirubicin—Doxorubicin—bone cancer	0.000897	0.16	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Doxorubicin—bone cancer	0.000897	0.16	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Doxorubicin—bone cancer	0.000897	0.16	CbGdCrCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—DHFR—bone cancer	0.0007	0.0204	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000637	0.0186	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000634	0.0185	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—EGFR—bone cancer	0.000604	0.0176	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—ZW10—bone cancer	0.000602	0.0176	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000542	0.0158	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—ZW10—bone cancer	0.000539	0.0157	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000522	0.0152	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—TP53—bone cancer	0.000507	0.0148	CbGpPWpGaD
Moxifloxacin—Levofloxacin—CYP3A4—bone cancer	0.000494	0.36	CrCbGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000493	0.0144	CbGpPWpGaD
Moxifloxacin—Ciprofloxacin—CYP3A4—bone cancer	0.000477	0.348	CrCbGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—GNA11—bone cancer	0.000476	0.0139	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—EZH2—bone cancer	0.000474	0.0138	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000457	0.0133	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000454	0.0133	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000449	0.0131	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000443	0.0129	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	0.000414	0.0121	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TUBB4B—bone cancer	0.000408	0.0119	CbGpPWpGaD
Moxifloxacin—Norfloxacin—CYP3A4—bone cancer	0.0004	0.292	CrCbGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000387	0.0113	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000375	0.011	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RFC1—bone cancer	0.00037	0.0108	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000368	0.0107	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	0.00032	0.00933	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000278	0.00813	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—CDK4—bone cancer	0.000267	0.0078	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	0.000257	0.00749	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—DHFR—bone cancer	0.000229	0.0067	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000222	0.00648	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000206	0.00602	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000199	0.00581	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CHEK2—bone cancer	0.000192	0.0056	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000179	0.00524	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—JUN—bone cancer	0.000172	0.00503	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—BRCA2—bone cancer	0.000163	0.00474	CbGpPWpGaD
Moxifloxacin—Renal failure—Doxorubicin—bone cancer	0.000149	0.000674	CcSEcCtD
Moxifloxacin—Erythema multiforme—Methotrexate—bone cancer	0.000148	0.000672	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Doxorubicin—bone cancer	0.000148	0.000672	CcSEcCtD
Moxifloxacin—Haemoglobin—Epirubicin—bone cancer	0.000147	0.000669	CcSEcCtD
Moxifloxacin—Stomatitis—Doxorubicin—bone cancer	0.000147	0.000669	CcSEcCtD
Moxifloxacin—Jaundice—Doxorubicin—bone cancer	0.000147	0.000669	CcSEcCtD
Moxifloxacin—Rhinitis—Epirubicin—bone cancer	0.000147	0.000667	CcSEcCtD
Moxifloxacin—Urinary tract infection—Doxorubicin—bone cancer	0.000147	0.000667	CcSEcCtD
Moxifloxacin—Conjunctivitis—Doxorubicin—bone cancer	0.000147	0.000667	CcSEcCtD
Moxifloxacin—Haemorrhage—Epirubicin—bone cancer	0.000147	0.000666	CcSEcCtD
Moxifloxacin—Hepatitis—Epirubicin—bone cancer	0.000147	0.000666	CcSEcCtD
Moxifloxacin—Eye disorder—Methotrexate—bone cancer	0.000146	0.000665	CcSEcCtD
Moxifloxacin—Tinnitus—Methotrexate—bone cancer	0.000146	0.000663	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Epirubicin—bone cancer	0.000146	0.000662	CcSEcCtD
Moxifloxacin—Asthenia—Cisplatin—bone cancer	0.000146	0.000661	CcSEcCtD
Moxifloxacin—Pharyngitis—Epirubicin—bone cancer	0.000145	0.000661	CcSEcCtD
Moxifloxacin—Cardiac disorder—Methotrexate—bone cancer	0.000145	0.00066	CcSEcCtD
Moxifloxacin—Sweating—Doxorubicin—bone cancer	0.000145	0.000658	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Epirubicin—bone cancer	0.000145	0.000657	CcSEcCtD
Moxifloxacin—Oedema peripheral—Epirubicin—bone cancer	0.000144	0.000656	CcSEcCtD
Moxifloxacin—Haematuria—Doxorubicin—bone cancer	0.000144	0.000654	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Epirubicin—bone cancer	0.000144	0.000654	CcSEcCtD
Moxifloxacin—Urethral disorder—Epirubicin—bone cancer	0.000144	0.000652	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Doxorubicin—bone cancer	0.000143	0.000649	CcSEcCtD
Moxifloxacin—Epistaxis—Doxorubicin—bone cancer	0.000143	0.000647	CcSEcCtD
Moxifloxacin—Angiopathy—Methotrexate—bone cancer	0.000142	0.000645	CcSEcCtD
Moxifloxacin—Sinusitis—Doxorubicin—bone cancer	0.000142	0.000644	CcSEcCtD
Moxifloxacin—Immune system disorder—Methotrexate—bone cancer	0.000141	0.000642	CcSEcCtD
Moxifloxacin—Visual impairment—Epirubicin—bone cancer	0.000141	0.000641	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Methotrexate—bone cancer	0.000141	0.000641	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000141	0.00412	CbGpPWpGaD
Moxifloxacin—Agranulocytosis—Doxorubicin—bone cancer	0.000141	0.00064	CcSEcCtD
Moxifloxacin—Chills—Methotrexate—bone cancer	0.000141	0.000638	CcSEcCtD
Moxifloxacin—Diarrhoea—Cisplatin—bone cancer	0.000139	0.00063	CcSEcCtD
Moxifloxacin—Erythema multiforme—Epirubicin—bone cancer	0.000139	0.000629	CcSEcCtD
Moxifloxacin—Bradycardia—Doxorubicin—bone cancer	0.000138	0.000627	CcSEcCtD
Moxifloxacin—Mental disorder—Methotrexate—bone cancer	0.000137	0.000623	CcSEcCtD
Moxifloxacin—Eye disorder—Epirubicin—bone cancer	0.000137	0.000622	CcSEcCtD
Moxifloxacin—Tinnitus—Epirubicin—bone cancer	0.000137	0.000621	CcSEcCtD
Moxifloxacin—Erythema—Methotrexate—bone cancer	0.000136	0.000619	CcSEcCtD
Moxifloxacin—Malnutrition—Methotrexate—bone cancer	0.000136	0.000619	CcSEcCtD
Moxifloxacin—Haemoglobin—Doxorubicin—bone cancer	0.000136	0.000619	CcSEcCtD
Moxifloxacin—Cardiac disorder—Epirubicin—bone cancer	0.000136	0.000618	CcSEcCtD
Moxifloxacin—Rhinitis—Doxorubicin—bone cancer	0.000136	0.000617	CcSEcCtD
Moxifloxacin—Hepatitis—Doxorubicin—bone cancer	0.000136	0.000616	CcSEcCtD
Moxifloxacin—Haemorrhage—Doxorubicin—bone cancer	0.000136	0.000616	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Doxorubicin—bone cancer	0.000135	0.000613	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	0.000135	0.00393	CbGpPWpGaD
Moxifloxacin—Pharyngitis—Doxorubicin—bone cancer	0.000135	0.000611	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Doxorubicin—bone cancer	0.000134	0.000608	CcSEcCtD
Moxifloxacin—Oedema peripheral—Doxorubicin—bone cancer	0.000134	0.000607	CcSEcCtD
Moxifloxacin—Dysgeusia—Methotrexate—bone cancer	0.000134	0.000606	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Doxorubicin—bone cancer	0.000133	0.000605	CcSEcCtD
Moxifloxacin—Angiopathy—Epirubicin—bone cancer	0.000133	0.000604	CcSEcCtD
Moxifloxacin—Urethral disorder—Doxorubicin—bone cancer	0.000133	0.000604	CcSEcCtD
Moxifloxacin—Immune system disorder—Epirubicin—bone cancer	0.000132	0.000601	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Epirubicin—bone cancer	0.000132	0.0006	CcSEcCtD
Moxifloxacin—Back pain—Methotrexate—bone cancer	0.000132	0.000599	CcSEcCtD
Moxifloxacin—Chills—Epirubicin—bone cancer	0.000132	0.000597	CcSEcCtD
Moxifloxacin—Arrhythmia—Epirubicin—bone cancer	0.000131	0.000595	CcSEcCtD
Moxifloxacin—Visual impairment—Doxorubicin—bone cancer	0.000131	0.000593	CcSEcCtD
Moxifloxacin—Vomiting—Cisplatin—bone cancer	0.000129	0.000585	CcSEcCtD
Moxifloxacin—Vision blurred—Methotrexate—bone cancer	0.000129	0.000583	CcSEcCtD
Moxifloxacin—Mental disorder—Epirubicin—bone cancer	0.000128	0.000583	CcSEcCtD
Moxifloxacin—Erythema multiforme—Doxorubicin—bone cancer	0.000128	0.000582	CcSEcCtD
Moxifloxacin—Rash—Cisplatin—bone cancer	0.000128	0.000581	CcSEcCtD
Moxifloxacin—Dermatitis—Cisplatin—bone cancer	0.000128	0.00058	CcSEcCtD
Moxifloxacin—Malnutrition—Epirubicin—bone cancer	0.000128	0.000579	CcSEcCtD
Moxifloxacin—Erythema—Epirubicin—bone cancer	0.000128	0.000579	CcSEcCtD
Moxifloxacin—Eye disorder—Doxorubicin—bone cancer	0.000127	0.000575	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Methotrexate—bone cancer	0.000127	0.000574	CcSEcCtD
Moxifloxacin—Tinnitus—Doxorubicin—bone cancer	0.000126	0.000574	CcSEcCtD
Moxifloxacin—Anaemia—Methotrexate—bone cancer	0.000126	0.000572	CcSEcCtD
Moxifloxacin—Cardiac disorder—Doxorubicin—bone cancer	0.000126	0.000572	CcSEcCtD
Moxifloxacin—Flatulence—Epirubicin—bone cancer	0.000126	0.000571	CcSEcCtD
Moxifloxacin—Tension—Epirubicin—bone cancer	0.000125	0.000569	CcSEcCtD
Moxifloxacin—Dysgeusia—Epirubicin—bone cancer	0.000125	0.000567	CcSEcCtD
Moxifloxacin—Nervousness—Epirubicin—bone cancer	0.000124	0.000563	CcSEcCtD
Moxifloxacin—Back pain—Epirubicin—bone cancer	0.000123	0.00056	CcSEcCtD
Moxifloxacin—Angiopathy—Doxorubicin—bone cancer	0.000123	0.000559	CcSEcCtD
Moxifloxacin—Malaise—Methotrexate—bone cancer	0.000123	0.000558	CcSEcCtD
Moxifloxacin—Muscle spasms—Epirubicin—bone cancer	0.000123	0.000557	CcSEcCtD
Moxifloxacin—Immune system disorder—Doxorubicin—bone cancer	0.000123	0.000556	CcSEcCtD
Moxifloxacin—Vertigo—Methotrexate—bone cancer	0.000123	0.000556	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Doxorubicin—bone cancer	0.000122	0.000555	CcSEcCtD
Moxifloxacin—Leukopenia—Methotrexate—bone cancer	0.000122	0.000554	CcSEcCtD
Moxifloxacin—Chills—Doxorubicin—bone cancer	0.000122	0.000553	CcSEcCtD
Moxifloxacin—Arrhythmia—Doxorubicin—bone cancer	0.000121	0.00055	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CDK4—bone cancer	0.000121	0.00352	CbGpPWpGaD
Moxifloxacin—Nausea—Cisplatin—bone cancer	0.00012	0.000547	CcSEcCtD
Moxifloxacin—Vision blurred—Epirubicin—bone cancer	0.00012	0.000546	CcSEcCtD
Moxifloxacin—Cough—Methotrexate—bone cancer	0.000119	0.00054	CcSEcCtD
Moxifloxacin—Mental disorder—Doxorubicin—bone cancer	0.000119	0.00054	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000118	0.00346	CbGpPWpGaD
Moxifloxacin—Ill-defined disorder—Epirubicin—bone cancer	0.000118	0.000538	CcSEcCtD
Moxifloxacin—Convulsion—Methotrexate—bone cancer	0.000118	0.000536	CcSEcCtD
Moxifloxacin—Erythema—Doxorubicin—bone cancer	0.000118	0.000536	CcSEcCtD
Moxifloxacin—Malnutrition—Doxorubicin—bone cancer	0.000118	0.000536	CcSEcCtD
Moxifloxacin—Anaemia—Epirubicin—bone cancer	0.000118	0.000535	CcSEcCtD
Moxifloxacin—Agitation—Epirubicin—bone cancer	0.000117	0.000532	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	0.000117	0.00342	CbGpPWpGaD
Moxifloxacin—Flatulence—Doxorubicin—bone cancer	0.000116	0.000528	CcSEcCtD
Moxifloxacin—Chest pain—Methotrexate—bone cancer	0.000116	0.000527	CcSEcCtD
Moxifloxacin—Arthralgia—Methotrexate—bone cancer	0.000116	0.000527	CcSEcCtD
Moxifloxacin—Myalgia—Methotrexate—bone cancer	0.000116	0.000527	CcSEcCtD
Moxifloxacin—Tension—Doxorubicin—bone cancer	0.000116	0.000526	CcSEcCtD
Moxifloxacin—Dysgeusia—Doxorubicin—bone cancer	0.000116	0.000525	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000115	0.000523	CcSEcCtD
Moxifloxacin—Malaise—Epirubicin—bone cancer	0.000115	0.000522	CcSEcCtD
Moxifloxacin—Discomfort—Methotrexate—bone cancer	0.000115	0.000521	CcSEcCtD
Moxifloxacin—Nervousness—Doxorubicin—bone cancer	0.000115	0.000521	CcSEcCtD
Moxifloxacin—Vertigo—Epirubicin—bone cancer	0.000115	0.000521	CcSEcCtD
Moxifloxacin—Syncope—Epirubicin—bone cancer	0.000114	0.00052	CcSEcCtD
Moxifloxacin—Leukopenia—Epirubicin—bone cancer	0.000114	0.000519	CcSEcCtD
Moxifloxacin—Back pain—Doxorubicin—bone cancer	0.000114	0.000519	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—TP53—bone cancer	0.000114	0.00332	CbGpPWpGaD
Moxifloxacin—Muscle spasms—Doxorubicin—bone cancer	0.000114	0.000515	CcSEcCtD
Moxifloxacin—Palpitations—Epirubicin—bone cancer	0.000113	0.000512	CcSEcCtD
Moxifloxacin—Confusional state—Methotrexate—bone cancer	0.000112	0.000509	CcSEcCtD
Moxifloxacin—Loss of consciousness—Epirubicin—bone cancer	0.000112	0.000509	CcSEcCtD
Moxifloxacin—Cough—Epirubicin—bone cancer	0.000111	0.000506	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Methotrexate—bone cancer	0.000111	0.000505	CcSEcCtD
Moxifloxacin—Vision blurred—Doxorubicin—bone cancer	0.000111	0.000505	CcSEcCtD
Moxifloxacin—Convulsion—Epirubicin—bone cancer	0.000111	0.000502	CcSEcCtD
Moxifloxacin—Hypertension—Epirubicin—bone cancer	0.00011	0.0005	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Doxorubicin—bone cancer	0.00011	0.000497	CcSEcCtD
Moxifloxacin—Nervous system disorder—Methotrexate—bone cancer	0.000109	0.000495	CcSEcCtD
Moxifloxacin—Anaemia—Doxorubicin—bone cancer	0.000109	0.000495	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Methotrexate—bone cancer	0.000109	0.000495	CcSEcCtD
Moxifloxacin—Myalgia—Epirubicin—bone cancer	0.000109	0.000493	CcSEcCtD
Moxifloxacin—Chest pain—Epirubicin—bone cancer	0.000109	0.000493	CcSEcCtD
Moxifloxacin—Arthralgia—Epirubicin—bone cancer	0.000109	0.000493	CcSEcCtD
Moxifloxacin—Agitation—Doxorubicin—bone cancer	0.000109	0.000493	CcSEcCtD
Moxifloxacin—Anxiety—Epirubicin—bone cancer	0.000108	0.000492	CcSEcCtD
Moxifloxacin—Skin disorder—Methotrexate—bone cancer	0.000108	0.000491	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000108	0.00049	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Methotrexate—bone cancer	0.000108	0.000488	CcSEcCtD
Moxifloxacin—Discomfort—Epirubicin—bone cancer	0.000107	0.000487	CcSEcCtD
Moxifloxacin—Malaise—Doxorubicin—bone cancer	0.000106	0.000483	CcSEcCtD
Moxifloxacin—Dry mouth—Epirubicin—bone cancer	0.000106	0.000482	CcSEcCtD
Moxifloxacin—Vertigo—Doxorubicin—bone cancer	0.000106	0.000482	CcSEcCtD
Moxifloxacin—Anorexia—Methotrexate—bone cancer	0.000106	0.000482	CcSEcCtD
Moxifloxacin—Syncope—Doxorubicin—bone cancer	0.000106	0.000481	CcSEcCtD
Moxifloxacin—Leukopenia—Doxorubicin—bone cancer	0.000106	0.00048	CcSEcCtD
Moxifloxacin—Confusional state—Epirubicin—bone cancer	0.000105	0.000477	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—RB1—bone cancer	0.000105	0.00306	CbGpPWpGaD
Moxifloxacin—Palpitations—Doxorubicin—bone cancer	0.000104	0.000474	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Epirubicin—bone cancer	0.000104	0.000473	CcSEcCtD
Moxifloxacin—Oedema—Epirubicin—bone cancer	0.000104	0.000473	CcSEcCtD
Moxifloxacin—Hypotension—Methotrexate—bone cancer	0.000104	0.000472	CcSEcCtD
Moxifloxacin—Loss of consciousness—Doxorubicin—bone cancer	0.000104	0.000471	CcSEcCtD
Moxifloxacin—Cough—Doxorubicin—bone cancer	0.000103	0.000468	CcSEcCtD
Moxifloxacin—Shock—Epirubicin—bone cancer	0.000102	0.000465	CcSEcCtD
Moxifloxacin—Convulsion—Doxorubicin—bone cancer	0.000102	0.000464	CcSEcCtD
Moxifloxacin—Nervous system disorder—Epirubicin—bone cancer	0.000102	0.000464	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Epirubicin—bone cancer	0.000102	0.000463	CcSEcCtD
Moxifloxacin—Hypertension—Doxorubicin—bone cancer	0.000102	0.000463	CcSEcCtD
Moxifloxacin—Tachycardia—Epirubicin—bone cancer	0.000102	0.000461	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000101	0.00046	CcSEcCtD
Moxifloxacin—Skin disorder—Epirubicin—bone cancer	0.000101	0.000459	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Epirubicin—bone cancer	0.000101	0.000457	CcSEcCtD
Moxifloxacin—Insomnia—Methotrexate—bone cancer	0.000101	0.000457	CcSEcCtD
Moxifloxacin—Arthralgia—Doxorubicin—bone cancer	0.000101	0.000456	CcSEcCtD
Moxifloxacin—Myalgia—Doxorubicin—bone cancer	0.000101	0.000456	CcSEcCtD
Moxifloxacin—Chest pain—Doxorubicin—bone cancer	0.000101	0.000456	CcSEcCtD
Moxifloxacin—Anxiety—Doxorubicin—bone cancer	0.0001	0.000455	CcSEcCtD
Moxifloxacin—Paraesthesia—Methotrexate—bone cancer	9.99e-05	0.000454	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	9.98e-05	0.000453	CcSEcCtD
Moxifloxacin—Discomfort—Doxorubicin—bone cancer	9.93e-05	0.000451	CcSEcCtD
Moxifloxacin—Anorexia—Epirubicin—bone cancer	9.93e-05	0.000451	CcSEcCtD
Moxifloxacin—Dyspnoea—Methotrexate—bone cancer	9.92e-05	0.00045	CcSEcCtD
Moxifloxacin—Somnolence—Methotrexate—bone cancer	9.89e-05	0.000449	CcSEcCtD
Moxifloxacin—Dry mouth—Doxorubicin—bone cancer	9.83e-05	0.000446	CcSEcCtD
Moxifloxacin—Dyspepsia—Methotrexate—bone cancer	9.8e-05	0.000445	CcSEcCtD
Moxifloxacin—Hypotension—Epirubicin—bone cancer	9.73e-05	0.000442	CcSEcCtD
Moxifloxacin—Confusional state—Doxorubicin—bone cancer	9.72e-05	0.000441	CcSEcCtD
Moxifloxacin—Decreased appetite—Methotrexate—bone cancer	9.67e-05	0.000439	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Doxorubicin—bone cancer	9.64e-05	0.000438	CcSEcCtD
Moxifloxacin—Oedema—Doxorubicin—bone cancer	9.64e-05	0.000438	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Methotrexate—bone cancer	9.61e-05	0.000436	CcSEcCtD
Moxifloxacin—Fatigue—Methotrexate—bone cancer	9.59e-05	0.000436	CcSEcCtD
Moxifloxacin—Pain—Methotrexate—bone cancer	9.52e-05	0.000432	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Epirubicin—bone cancer	9.49e-05	0.000431	CcSEcCtD
Moxifloxacin—Shock—Doxorubicin—bone cancer	9.48e-05	0.00043	CcSEcCtD
Moxifloxacin—Nervous system disorder—Doxorubicin—bone cancer	9.45e-05	0.000429	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Doxorubicin—bone cancer	9.44e-05	0.000428	CcSEcCtD
Moxifloxacin—Insomnia—Epirubicin—bone cancer	9.42e-05	0.000428	CcSEcCtD
Moxifloxacin—Tachycardia—Doxorubicin—bone cancer	9.41e-05	0.000427	CcSEcCtD
Moxifloxacin—Skin disorder—Doxorubicin—bone cancer	9.36e-05	0.000425	CcSEcCtD
Moxifloxacin—Paraesthesia—Epirubicin—bone cancer	9.35e-05	0.000425	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Doxorubicin—bone cancer	9.32e-05	0.000423	CcSEcCtD
Moxifloxacin—Dyspnoea—Epirubicin—bone cancer	9.29e-05	0.000422	CcSEcCtD
Moxifloxacin—Somnolence—Epirubicin—bone cancer	9.26e-05	0.00042	CcSEcCtD
Moxifloxacin—Anorexia—Doxorubicin—bone cancer	9.19e-05	0.000417	CcSEcCtD
Moxifloxacin—Feeling abnormal—Methotrexate—bone cancer	9.17e-05	0.000416	CcSEcCtD
Moxifloxacin—Dyspepsia—Epirubicin—bone cancer	9.17e-05	0.000416	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Methotrexate—bone cancer	9.1e-05	0.000413	CcSEcCtD
Moxifloxacin—Decreased appetite—Epirubicin—bone cancer	9.05e-05	0.000411	CcSEcCtD
Moxifloxacin—Hypotension—Doxorubicin—bone cancer	9e-05	0.000409	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Epirubicin—bone cancer	8.99e-05	0.000408	CcSEcCtD
Moxifloxacin—Fatigue—Epirubicin—bone cancer	8.98e-05	0.000408	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—MDM2—bone cancer	8.94e-05	0.00261	CbGpPWpGaD
Moxifloxacin—Pain—Epirubicin—bone cancer	8.91e-05	0.000404	CcSEcCtD
Moxifloxacin—Constipation—Epirubicin—bone cancer	8.91e-05	0.000404	CcSEcCtD
Moxifloxacin—Urticaria—Methotrexate—bone cancer	8.84e-05	0.000401	CcSEcCtD
Moxifloxacin—Abdominal pain—Methotrexate—bone cancer	8.8e-05	0.000399	CcSEcCtD
Moxifloxacin—Body temperature increased—Methotrexate—bone cancer	8.8e-05	0.000399	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Doxorubicin—bone cancer	8.78e-05	0.000399	CcSEcCtD
Moxifloxacin—Insomnia—Doxorubicin—bone cancer	8.72e-05	0.000396	CcSEcCtD
Moxifloxacin—Paraesthesia—Doxorubicin—bone cancer	8.65e-05	0.000393	CcSEcCtD
Moxifloxacin—Dyspnoea—Doxorubicin—bone cancer	8.59e-05	0.00039	CcSEcCtD
Moxifloxacin—Feeling abnormal—Epirubicin—bone cancer	8.58e-05	0.00039	CcSEcCtD
Moxifloxacin—Somnolence—Doxorubicin—bone cancer	8.57e-05	0.000389	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Epirubicin—bone cancer	8.52e-05	0.000387	CcSEcCtD
Moxifloxacin—Dyspepsia—Doxorubicin—bone cancer	8.48e-05	0.000385	CcSEcCtD
Moxifloxacin—Decreased appetite—Doxorubicin—bone cancer	8.38e-05	0.00038	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Doxorubicin—bone cancer	8.32e-05	0.000378	CcSEcCtD
Moxifloxacin—Fatigue—Doxorubicin—bone cancer	8.31e-05	0.000377	CcSEcCtD
Moxifloxacin—Urticaria—Epirubicin—bone cancer	8.27e-05	0.000376	CcSEcCtD
Moxifloxacin—Pain—Doxorubicin—bone cancer	8.24e-05	0.000374	CcSEcCtD
Moxifloxacin—Constipation—Doxorubicin—bone cancer	8.24e-05	0.000374	CcSEcCtD
Moxifloxacin—Abdominal pain—Epirubicin—bone cancer	8.23e-05	0.000374	CcSEcCtD
Moxifloxacin—Body temperature increased—Epirubicin—bone cancer	8.23e-05	0.000374	CcSEcCtD
Moxifloxacin—Hypersensitivity—Methotrexate—bone cancer	8.2e-05	0.000372	CcSEcCtD
Moxifloxacin—Asthenia—Methotrexate—bone cancer	7.98e-05	0.000363	CcSEcCtD
Moxifloxacin—Feeling abnormal—Doxorubicin—bone cancer	7.94e-05	0.000361	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Doxorubicin—bone cancer	7.88e-05	0.000358	CcSEcCtD
Moxifloxacin—Pruritus—Methotrexate—bone cancer	7.87e-05	0.000357	CcSEcCtD
Moxifloxacin—Hypersensitivity—Epirubicin—bone cancer	7.67e-05	0.000348	CcSEcCtD
Moxifloxacin—Urticaria—Doxorubicin—bone cancer	7.66e-05	0.000348	CcSEcCtD
Moxifloxacin—Abdominal pain—Doxorubicin—bone cancer	7.62e-05	0.000346	CcSEcCtD
Moxifloxacin—Body temperature increased—Doxorubicin—bone cancer	7.62e-05	0.000346	CcSEcCtD
Moxifloxacin—Diarrhoea—Methotrexate—bone cancer	7.61e-05	0.000346	CcSEcCtD
Moxifloxacin—Asthenia—Epirubicin—bone cancer	7.47e-05	0.000339	CcSEcCtD
Moxifloxacin—Pruritus—Epirubicin—bone cancer	7.37e-05	0.000335	CcSEcCtD
Moxifloxacin—Dizziness—Methotrexate—bone cancer	7.36e-05	0.000334	CcSEcCtD
Moxifloxacin—Diarrhoea—Epirubicin—bone cancer	7.13e-05	0.000324	CcSEcCtD
Moxifloxacin—Hypersensitivity—Doxorubicin—bone cancer	7.1e-05	0.000322	CcSEcCtD
Moxifloxacin—Vomiting—Methotrexate—bone cancer	7.08e-05	0.000321	CcSEcCtD
Moxifloxacin—Rash—Methotrexate—bone cancer	7.02e-05	0.000319	CcSEcCtD
Moxifloxacin—Dermatitis—Methotrexate—bone cancer	7.01e-05	0.000318	CcSEcCtD
Moxifloxacin—Headache—Methotrexate—bone cancer	6.97e-05	0.000317	CcSEcCtD
Moxifloxacin—Asthenia—Doxorubicin—bone cancer	6.91e-05	0.000314	CcSEcCtD
Moxifloxacin—Dizziness—Epirubicin—bone cancer	6.89e-05	0.000313	CcSEcCtD
Moxifloxacin—Pruritus—Doxorubicin—bone cancer	6.82e-05	0.00031	CcSEcCtD
Moxifloxacin—Vomiting—Epirubicin—bone cancer	6.62e-05	0.000301	CcSEcCtD
Moxifloxacin—Nausea—Methotrexate—bone cancer	6.61e-05	0.0003	CcSEcCtD
Moxifloxacin—Diarrhoea—Doxorubicin—bone cancer	6.59e-05	0.000299	CcSEcCtD
Moxifloxacin—Rash—Epirubicin—bone cancer	6.57e-05	0.000298	CcSEcCtD
Moxifloxacin—Dermatitis—Epirubicin—bone cancer	6.56e-05	0.000298	CcSEcCtD
Moxifloxacin—Headache—Epirubicin—bone cancer	6.52e-05	0.000296	CcSEcCtD
Moxifloxacin—Dizziness—Doxorubicin—bone cancer	6.37e-05	0.000289	CcSEcCtD
Moxifloxacin—Nausea—Epirubicin—bone cancer	6.19e-05	0.000281	CcSEcCtD
Moxifloxacin—Vomiting—Doxorubicin—bone cancer	6.13e-05	0.000278	CcSEcCtD
Moxifloxacin—Rash—Doxorubicin—bone cancer	6.08e-05	0.000276	CcSEcCtD
Moxifloxacin—Dermatitis—Doxorubicin—bone cancer	6.07e-05	0.000276	CcSEcCtD
Moxifloxacin—Headache—Doxorubicin—bone cancer	6.04e-05	0.000274	CcSEcCtD
Moxifloxacin—Nausea—Doxorubicin—bone cancer	5.72e-05	0.00026	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—TP53—bone cancer	5.13e-05	0.0015	CbGpPWpGaD
